Literature DB >> 24554817

Epstein-barr virus infection masquerading as acute leukemia: a report of two cases and review of literature.

Puneet Chhabra1, Arjun Dutt Law1, Upender Sharma2, Vikas Suri1, Manupdesh Singh Sachdeva3, Savita Kumari1, Subhash Varma1, Pankaj Malhotra1.   

Abstract

Epstein-Barr virus (EBV) is the first herpes virus to be completely sequenced. It is implicated in diseases from the benign infectious mononucleosis to malignant nasopharyngeal carcinoma, Burkitt's lymphoma and primary CNS lymphoma in AIDS patients. It has also been found to be associated with some miscellaneous diseases like chronic fatigue syndrome, multiple sclerosis etc. however causality still remains an issue of debate. As the virus mainly targets the lymphomonuclear cells and the reticuloendothelial system of the body, it's various manifestations are often mistaken as leukemic malignancies. We report two such cases of young adults who had been diagnosed as having acute leukemia on the basis of atypical cells in the peripheral blood. One patient later turned out to be a classical infectious mononucleosis and second patient had EBV associated hemophagocytic lymphohistiocytosis syndrome.

Entities:  

Keywords:  Acute leukemia; Epstein–Barr virus; Hemophagocytic lymphohistiocytosis; Infectious mononucleosis

Year:  2012        PMID: 24554817      PMCID: PMC3921326          DOI: 10.1007/s12288-012-0207-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  10 in total

1.  EBV associated hemophagocytic lymphohistiocytosis with spontaneous regression.

Authors:  Sameer Bakhshi; Jeremy L Pautu
Journal:  Indian Pediatr       Date:  2005-12       Impact factor: 1.411

2.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

Review 3.  Infectious mononucleosis.

Authors:  D T Karzon
Journal:  Adv Pediatr       Date:  1976

4.  Primary Epstein-Barr-virus infections in acute neurologic diseases.

Authors:  C Grose; W Henle; G Henle; P M Feorino
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

Review 5.  The atypical lymphocyte.

Authors:  T A Wood; E P Frenkel
Journal:  Am J Med       Date:  1967-06       Impact factor: 4.965

6.  Fatal haemophagocytic syndrome.

Authors:  S A Fadilah; A A Raymond; S K Cheong; M A Amir
Journal:  Med J Malaysia       Date:  2001-12

7.  Down-regulation of pan-T-cell antigens, particularly CD7, in acute infectious mononucleosis.

Authors:  James Weisberger; Dennis Cornfield; Wojciech Gorczyca; Zach Liu
Journal:  Am J Clin Pathol       Date:  2003-07       Impact factor: 2.493

8.  An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry.

Authors:  Wojciech Gorczyca; James Weisberger; Z Liu; Patricia Tsang; Monowar Hossein; C Daniel Wu; Henry Dong; John Y L Wong; Sorina Tugulea; Simpson Dee; Myron R Melamed; Zbigniew Darzynkiewicz
Journal:  Cytometry       Date:  2002-06-15

Review 9.  Diagnostic evaluation of mononucleosis-like illnesses.

Authors:  Christopher Hurt; Dominick Tammaro
Journal:  Am J Med       Date:  2007-10       Impact factor: 4.965

Review 10.  Viral infections associated with haemophagocytic syndrome.

Authors:  Nadine Rouphael Maakaroun; Abeer Moanna; Jesse T Jacob; Helmut Albrecht
Journal:  Rev Med Virol       Date:  2010-03       Impact factor: 6.989

  10 in total
  2 in total

1.  Offender: virus or parasite or both.

Authors:  P Chhabra
Journal:  J Postgrad Med       Date:  2015 Apr-Jun       Impact factor: 1.476

Review 2.  The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog.

Authors:  Heather M Long; Benjamin J Meckiff; Graham S Taylor
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.